Pharmaceutical giant Johnson & Johnson has reached a $1 billion deal to develop and deliver 100 million doses of a coronavirus vaccine with the option for the United States to order 200 million more. The vaccine is currently in early human trials and will likely move to late stage testing in September. According to the U.S. Department of Health and Human Services, the doses will be provided to Americans at no-cost. Johnson & Johnson also aims to distribute 1 billion vaccines throughout 2021. They are the latest company to reach a deal with the U.S Government to develop a vaccine, following other drugmakers like Sanofi and Pfizer.
Blake is a writer focused on non-profits and trade industries. He has told the stories of countless peacebuilders while covering international development with the nonprofit Search for Common Ground. He is a graduate of the George Washington University’s School of Media and Public Affairs.